Briggs Morrison Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Briggs Morrison.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Briggs Morrison. Briggs Morrison is Chief Executive Officer in Syndax Pharmaceuticals Inc ($SNDX) and Director in ARVINAS HOLDING COMPANY, LLC ($ARVN) and Director in Codiak BioSciences, Inc. ($CDAK) and Director in NextCure, Inc. ($NXTC) and Director in Repare Therapeutics Inc. ($RPTX).
Latest Insider Trading Transactions of Briggs Morrison
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARVN, CDAK, NXTC, RPTX, SNDX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | RPTX | Repare Therapeutic ... | Morrison Briggs | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
| May 14 2021 | RPTX | Repare Therapeutic ... | Morrison Briggs | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
| Feb 10 2021 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Option Exercise | M | 7.20 | 35,156 | 253,123 | 0 | |
| Feb 10 2021 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Sell | S | 20.55 | 35,156 | 722,403 | 48,336 | 83.5 K to 48.3 K (-42.11 %) |
| Feb 10 2021 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Buy | M | 7.20 | 35,156 | 253,123 | 83,492 | 48.3 K to 83.5 K (+72.73 %) |
| Nov 12 2020 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Option Exercise | M | 7.20 | 17,466 | 125,755 | 0 | |
| Nov 12 2020 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Option Exercise | M | 7.20 | 62,938 | 453,154 | 0 | |
| Nov 12 2020 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Sell | S | 20.06 | 17,466 | 350,312 | 46,565 | 64 K to 46.6 K (-27.28 %) |
| Nov 12 2020 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Buy | M | 7.20 | 17,466 | 125,755 | 64,031 | 46.6 K to 64 K (+37.51 %) |
| Nov 12 2020 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Sell | S | 20.04 | 62,938 | 1,261,265 | 46,565 | 109.5 K to 46.6 K (-57.48 %) |
| Nov 12 2020 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Buy | M | 7.20 | 62,938 | 453,154 | 109,503 | 46.6 K to 109.5 K (+135.16 %) |
| Oct 15 2020 | CDAK | Codiak BioSciences ... | Morrison Briggs | Director | Option Exercise | A | 15.00 | 10,000 | 150,000 | 10,000 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Morrison Briggs | Director | Buy | P | 20.00 | 4,800 | 96,000 | 4,800 | 0 to 4.8 K |
| Jun 15 2020 | NXTC | NextCure, Inc. | Morrison Briggs | Director | Option Exercise | A | 24.13 | 14,250 | 343,853 | 14,250 | |
| Jun 04 2020 | ARVN | ARVINAS, INC. | Morrison Briggs | Director | Option Exercise | A | 33.57 | 12,000 | 402,840 | 12,000 | |
| Mar 25 2020 | ARVN | ARVINAS, INC. | Morrison Briggs | Director | Buy | P | 38.18 | 2,500 | 95,450 | 29,520 | 27 K to 29.5 K (+9.25 %) |
| Feb 14 2020 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Option Exercise | A | 9.47 | 194,000 | 1,837,180 | 194,000 | |
| Feb 05 2020 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Buy | P | 8.00 | 12,500 | 100,000 | 43,900 | 31.4 K to 43.9 K (+39.81 %) |
| Oct 11 2019 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Buy | P | 5.40 | 11,000 | 59,400 | 31,400 | 20.4 K to 31.4 K (+53.92 %) |
| Jun 17 2019 | NXTC | NextCure, Inc. | Morrison Briggs | Director | Option Exercise | A | 15.57 | 22,000 | 342,540 | 22,000 | |
| May 28 2019 | ARVN | ARVINAS, INC. | Morrison Briggs | Director | Option Exercise | A | 22.06 | 12,923 | 285,081 | 12,923 | |
| May 13 2019 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Buy | P | 7.29 | 7,200 | 52,517 | 20,400 | 13.2 K to 20.4 K (+54.55 %) |
| May 13 2019 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Buy | P | 7.56 | 13,200 | 99,726 | 13,200 | 0 to 13.2 K |
| Sep 28 2018 | ARVN | ARVINAS HOLDING CO ... | Morrison Briggs | Director | Option Exercise | A | 16.00 | 32,870 | 525,920 | 32,870 | |
| Sep 28 2018 | ARVN | ARVINAS HOLDING CO ... | Morrison Briggs | Director | Option Exercise | A | 16.00 | 6,960 | 111,360 | 6,960 | |
| Feb 08 2017 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Option Exercise | A | 8.77 | 160,000 | 1,403,200 | 160,000 |
Page: 1